Acute 5-HT reuptake blockade potentiates human amygdala reactivity

Kristin L. Bigos; Bruce G. Pollock; Howard J. Aizenstein; Patrick M. Fisher; Robert R. Bies; Ahmad R. Hariri

doi:10.1038/npp.2008.52

Acute 5-HT reuptake blockade potentiates human amygdala reactivity

Kristin L. Bigos, Bruce G. Pollock, Howard J. Aizenstein, Patrick M. Fisher, Robert R. Bies, Ahmad R. Hariri

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Abstract

Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using pharmacological functional MRI. Eight healthy men completed a double-blind balanced crossover study with the selective 5-HT reuptake inhibitor, citalopram (20 mg infused over 30 min), and normal saline. Amygdala reactivity in response to novel facial expressions was assessed on three successive scans, once before drug/placebo infusion, once early in the infusion, and once at the end of infusion. Acute citalopram administration resulted in concentration-dependent increases in human amygdala reactivity to salient stimuli. The current pattern of 5-HT-mediated amygdala reactivity may represent an important pathway through which SSRIs achieve an antidepressant effect. Intriguingly, our data may also reveal a mechanism contributing to clinical observations of extreme agitation, restlessness, and suicidal ideation in some individuals during acute SSRI treatment. Developing a comprehensive model of how 5-HT modulates human amygdala reactivity supporting behavioral and physiological arousal will be instrumental for our understanding of basic neurobehavioral processes, their dysfunction in psychiatric illnesses, and their contribution to mechanism of treatment response.

Original language	English (US)
Pages (from-to)	3221-3225
Number of pages	5
Journal	Neuropsychopharmacology
Volume	33
Issue number	13
DOIs	https://doi.org/10.1038/npp.2008.52
State	Published - Dec 2008
Externally published	Yes

Keywords

Amygdala
Citalopram
Functional MRI
Healthy subjects
SSRI
Serotonin

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Access to Document

10.1038/npp.2008.52

Cite this

@article{31fe67590ee445f89549dc0eb85912f3,

title = "Acute 5-HT reuptake blockade potentiates human amygdala reactivity",

abstract = "Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using pharmacological functional MRI. Eight healthy men completed a double-blind balanced crossover study with the selective 5-HT reuptake inhibitor, citalopram (20 mg infused over 30 min), and normal saline. Amygdala reactivity in response to novel facial expressions was assessed on three successive scans, once before drug/placebo infusion, once early in the infusion, and once at the end of infusion. Acute citalopram administration resulted in concentration-dependent increases in human amygdala reactivity to salient stimuli. The current pattern of 5-HT-mediated amygdala reactivity may represent an important pathway through which SSRIs achieve an antidepressant effect. Intriguingly, our data may also reveal a mechanism contributing to clinical observations of extreme agitation, restlessness, and suicidal ideation in some individuals during acute SSRI treatment. Developing a comprehensive model of how 5-HT modulates human amygdala reactivity supporting behavioral and physiological arousal will be instrumental for our understanding of basic neurobehavioral processes, their dysfunction in psychiatric illnesses, and their contribution to mechanism of treatment response.",

keywords = "Amygdala, Citalopram, Functional MRI, Healthy subjects, SSRI, Serotonin",

author = "Bigos, {Kristin L.} and Pollock, {Bruce G.} and Aizenstein, {Howard J.} and Fisher, {Patrick M.} and Bies, {Robert R.} and Hariri, {Ahmad R.}",

note = "Funding Information: This research study was supported by NIH F31MH076420, K24MH065416, K23MH064678, K01MH072837, P41EB001975, and NARSAD. Support was also provided by the General Clinical Research Center of the University of Pittsburgh Medical Center (MO1RR000056) and the University of Pittsburgh Magnetic Resonance Research Center Pilot Imaging Program. Funding Information: In addition to the NIH grants listed above, Dr Pollock has received research support from Janssen Pharmaceuticals. He has served on the advisory board of Forest Laboratories and is a faculty member of the Lundbeck Institute. The other authors have no other disclosures or conflicts.",

year = "2008",

month = dec,

doi = "10.1038/npp.2008.52",

language = "English (US)",

volume = "33",

pages = "3221--3225",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "13",

}

TY - JOUR

T1 - Acute 5-HT reuptake blockade potentiates human amygdala reactivity

AU - Bigos, Kristin L.

AU - Pollock, Bruce G.

AU - Aizenstein, Howard J.

AU - Fisher, Patrick M.

AU - Bies, Robert R.

AU - Hariri, Ahmad R.

N1 - Funding Information: This research study was supported by NIH F31MH076420, K24MH065416, K23MH064678, K01MH072837, P41EB001975, and NARSAD. Support was also provided by the General Clinical Research Center of the University of Pittsburgh Medical Center (MO1RR000056) and the University of Pittsburgh Magnetic Resonance Research Center Pilot Imaging Program. Funding Information: In addition to the NIH grants listed above, Dr Pollock has received research support from Janssen Pharmaceuticals. He has served on the advisory board of Forest Laboratories and is a faculty member of the Lundbeck Institute. The other authors have no other disclosures or conflicts.

PY - 2008/12

Y1 - 2008/12

N2 - Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using pharmacological functional MRI. Eight healthy men completed a double-blind balanced crossover study with the selective 5-HT reuptake inhibitor, citalopram (20 mg infused over 30 min), and normal saline. Amygdala reactivity in response to novel facial expressions was assessed on three successive scans, once before drug/placebo infusion, once early in the infusion, and once at the end of infusion. Acute citalopram administration resulted in concentration-dependent increases in human amygdala reactivity to salient stimuli. The current pattern of 5-HT-mediated amygdala reactivity may represent an important pathway through which SSRIs achieve an antidepressant effect. Intriguingly, our data may also reveal a mechanism contributing to clinical observations of extreme agitation, restlessness, and suicidal ideation in some individuals during acute SSRI treatment. Developing a comprehensive model of how 5-HT modulates human amygdala reactivity supporting behavioral and physiological arousal will be instrumental for our understanding of basic neurobehavioral processes, their dysfunction in psychiatric illnesses, and their contribution to mechanism of treatment response.

AB - Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using pharmacological functional MRI. Eight healthy men completed a double-blind balanced crossover study with the selective 5-HT reuptake inhibitor, citalopram (20 mg infused over 30 min), and normal saline. Amygdala reactivity in response to novel facial expressions was assessed on three successive scans, once before drug/placebo infusion, once early in the infusion, and once at the end of infusion. Acute citalopram administration resulted in concentration-dependent increases in human amygdala reactivity to salient stimuli. The current pattern of 5-HT-mediated amygdala reactivity may represent an important pathway through which SSRIs achieve an antidepressant effect. Intriguingly, our data may also reveal a mechanism contributing to clinical observations of extreme agitation, restlessness, and suicidal ideation in some individuals during acute SSRI treatment. Developing a comprehensive model of how 5-HT modulates human amygdala reactivity supporting behavioral and physiological arousal will be instrumental for our understanding of basic neurobehavioral processes, their dysfunction in psychiatric illnesses, and their contribution to mechanism of treatment response.

KW - Amygdala

KW - Citalopram

KW - Functional MRI

KW - Healthy subjects

KW - SSRI

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=53449093719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449093719&partnerID=8YFLogxK

U2 - 10.1038/npp.2008.52

DO - 10.1038/npp.2008.52

M3 - Article

C2 - 18463627

AN - SCOPUS:53449093719

SN - 0893-133X

VL - 33

SP - 3221

EP - 3225

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 13

ER -

Acute 5-HT reuptake blockade potentiates human amygdala reactivity

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this